BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Products » [SALE] Global Database of CAR-T Cell Therapy Companies, 2022
Sale!
Database of CAR-T Cell Therapy Companies (2018) - BioInformant

[SALE] Global Database of CAR-T Cell Therapy Companies, 2022

SKU: N/A Category: Stem Cells Tag: CAR-T
  • Description

Description

The world’s only searchable, sortable database of CAR-T cell therapy companies worldwide that is publicly available.

CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as “living drugs.”

Discover class-defining bioproduction tools.

Since the first historic CAR-T approvals in 2017, Kymriah (tisagenlecleucel), Yescarta (axicabtagene ciloleucel), Tecartus (brexucabtagene autoleucel), Breyanzi (lisocabtagene maraleucel), Abecma (idecabtagene vicleucel), and Relma-cel (relmacabtagene autoleucel) have reached commercialization.

These historic approvals have driven the CAR-T market to staggering new heights and fueled a frenzy of interest into CAR-T cell therapy development. To track the competitors who compose this rapidly expanding market, BioInformant has released a global database of all known CAR-T cell therapy companies—currently 161 worldwide.

We originally developed this database for our own purposes, but more and more of our readers have requested access to it.

CAR-T Company Database

This database features the following information for all known CAR-T market competitors:

  • Company Name
  • CAR-T Technology
  • Disease Targets
  • Description of CAR-T Involvement
  • Country
  • City / State
  • Link to CAR-T Programs
  • Company Website

Use this searchable database of CAR-T companies to:

  1. Identify global competitors within the CAR-T marketplace
  2. Quantify CAR-T products in late-stage development
  3. Reveal preclinical and clinical programs supporting CAR-T development
  4. Spot regions that are “hotspots” for CAR-T companies
  5. Identify potential partners and collaborators

It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages.

Thankfully, we have a talented, multilingual team who is up to the task of organizing all known CAR-T companies worldwide. Because we continuously update this database to reflect new competitors entering the CAR-T cell therapy marketplace, we are confident that you will find it to be invaluable resource.

Guarantee

Remember, all BioInformant products come with a Greater Than 100% Money Back Guarantee. If the strategies and tools aren’t helpful to you – we’ll cheerfully refund your money, and you can keep the product.

For the next 24 hours, you can claim this database for an unusual 50% off. Act fast, because this offer expires soon!

$124 – $297

Clear

Related products

  • [NEW] The Global Market for Cultured Meat – Market Size, Trends, Competitors, and Forecasts (2022)

    $4,197 – $5,297
    Select options
  • Global Database of Research Supply Companies

    Global Database of Research Supply Companies 2021

    $39
    Add to cart
  • Sale! CAR-T Funding Brief

    [SALE] CAR-T Funding Brief – Financing Rounds, Acquisitions, & IPOs

    $197 $49
    Add to cart
  • Sale! Exosome Companies 2020

    Global Database of Exosome Companies

    $149 $97
    Add to cart

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.